Sponsored by Boston Scientific Corporation
evt | Article | April 2017 Supplement
evt | Article | February 2016
evt | Article | January 2016
evt | Article | March 2016
evt | News | October 20, 2016
Fifteen-Year Follow-Up Data From UK EVAR 1 Trial Published
October 20, 2016—Fifteen-year follow-up data from the landmark randomized controlled United Kingdom endovascular aneurysm repair trial 1 (EVAR 1) were published by Rajesh Patel, MD, et al online ahead of print in The Lancet. EVAR 1 was led by Chief Investigator Prof.
Sponsored by Cardinal Health (formerly AccessClosure)
evt | Article | February 2015
evt | Article | January 2007
evt | Article | November 2017
Sponsored by Ra Medical Systems, Inc.
evt | Article | August 2019
evt | Article | February 2017
The Advent of Flow Diversion and Its Implications for Cerebral Aneurysm Treatment
A discussion of the principles of flow diversion and current use of flow diversion devices by location and type of aneurysm.
By Matthew J. Koch, MD; Christopher J. Stapleton, MD; Brian P. Walcott, MD; Scott B. Raymond, MD, PhD; and Aman B. Patel, MD
evt | News | June 21, 2019
RESULTS Registry Will Evaluate 2-Year Outcomes With Ra Medical's DABRA Excimer Laser System
June 19, 2019—Ra Medical Systems, Inc. announced it is conducting a study to demonstrate the effectiveness of the company's DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) excimer laser photoablation system to deliver long-lasting results and a low reintervention rate for patients with peripheral artery disease.
Sponsored by CORDIS CORPORATION
evt | Article | August 2013 Supplement
evt | Article | June 2010
evt | Article | October 2011